CCR 20th Anniversary Commentary: Simpson's Paradox and Neoadjuvant Trials.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26374072.
- Also identified by DOI 10.1158/1078-0432.CCR-14-3124 and PMC identifier 4573539.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The research article by Carey and colleagues, published in the April 15, 2007, issue of Clinical Cancer Research, described the relationship between response to neoadjuvant chemotherapy and outcome by tumor subtype. Today neoadjuvant clinical trials are often designed to provide correlative data to help identify predictive biomarkers or to focus on poor-risk patients identified by residual disease after neoadjuvant treatment.
Medical subject headings
- Breast Neoplasms
- Chemotherapy, Adjuvant
- Neoadjuvant Therapy
- Neoplasm, Residual